Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Topic: News

Partnerships VarSome Clinical News

Gencell Pharma S.A.S. to adopt VarSome Clinical for high-throughput analysis of clinical exomes and genomes sequenced on MGI DNBSEQ-G400 and T7 platforms

By Carl Smith on March 29, 2022

VarSome is sponsoring this year'sAmerican Society of Human Genetics Virtual Annual Meeting, October 18-22.

Events News

VarSome at ASHG 2021

By Carl Smith on October 19, 2021

Saphetor was featured in a Forbes article this week, highlighting the companies doing great work in the UK genomics ecosystem. The article covers our founder and CEO, Andreas Massouras, VarSome, and the incredible growth of the company through smart...

News

Saphetor in Forbes

By Carl Smith on September 3, 2021

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Oxford Nanopore Technologies and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

CING studies ABT with the help of VarSome Clinical

Building the best in variant classification

Reclassifying VUS

Expanded biobanks, education, and genomics research investments - Saudi Arabia transforming healthcare

Building the best in variant classification

Company News listing page

Categories

Stay up to date

Topic: News

Gencell Pharma S.A.S. to adopt VarSome Clinical for high-throughput analysis of clinical exomes and genomes sequenced on MGI DNBSEQ-G400 and T7 platforms

VarSome at ASHG 2021

Saphetor in Forbes